Description
A newer investigational GLP-1/GIP dual agonist peptide (similar to tirzepatide). It targets weight reduction, glucose regulation, and metabolic improvements. Early studies show promise in obesity and type 2 diabetes management.
A newer investigational GLP-1/GIP dual agonist peptide (similar to tirzepatide). It targets weight reduction, glucose regulation, and metabolic improvements. Early studies show promise in obesity and type 2 diabetes management.
| DOSAGE | 10mg |
|---|




Reviews
There are no reviews yet.